OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
80 hedge funds and large institutions have $41M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
71% less call options, than puts
Call options by funds: $380K | Put options by funds: $1.33M
Holders
80
Holding in Top 10
–
Calls
$380K
Puts
$1.33M
Top Buyers
| 1 | +$446K | |
| 2 | +$443K | |
| 3 | +$331K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$211K |
| 5 |
Morgan Stanley
New York
|
+$146K |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$932K | |
| 3 | -$837K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$651K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$372K |